Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.

Hdl Handle:
http://hdl.handle.net/10144/203633
Title:
Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.
Authors:
Pujades-Rodríguez, Mar; Dantony, Emmanuelle; Pinoges, Loretxu; Ecochard, René; Etard, Jean-François; Carrillo-Casas, Esther; Szumilin, Elisabeth
Journal:
PLoS One
Abstract:
To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors.
Affiliation:
Clinical Research Department, Epicentre, Paris, France. mar.pujades@epicentre.msf.org
Issue Date:
Nov-2011
URI:
http://hdl.handle.net/10144/203633
DOI:
10.1371/journal.pone.0028112
PubMed ID:
22132226
Language:
en
ISSN:
1932-6203
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorPujades-Rodríguez, Maren
dc.contributor.authorDantony, Emmanuelleen
dc.contributor.authorPinoges, Loretxuen
dc.contributor.authorEcochard, Renéen
dc.contributor.authorEtard, Jean-Françoisen
dc.contributor.authorCarrillo-Casas, Estheren
dc.contributor.authorSzumilin, Elisabethen
dc.date.accessioned2012-01-18T17:28:28Z-
dc.date.available2012-01-18T17:28:28Z-
dc.date.issued2011-11-
dc.identifier.citationToxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy. 2011, 6 (11):e28112 PLoS ONEen
dc.identifier.issn1932-6203-
dc.identifier.pmid22132226-
dc.identifier.doi10.1371/journal.pone.0028112-
dc.identifier.urihttp://hdl.handle.net/10144/203633-
dc.description.abstractTo compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors.en
dc.language.isoenen
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen
dc.titleToxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.en
dc.contributor.departmentClinical Research Department, Epicentre, Paris, France. mar.pujades@epicentre.msf.orgen
dc.identifier.journalPLoS Oneen
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.